drugset / Trial / NCT02329288

Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION

NCT02329288

Phase 3 Unknown 60 enrolled Second Military Medical University
RandomizedParallel-groupDouble-blindTreatment

Summary

NAION produces an ischemic insult in the optic nerve head presumably due to the hypoperfusion of the short ciliary arteries that supply it. Intravenous injection of glucocorticoid have proven to be effective in treatment of Nonarteritic Anterior Ischemic Optic Neuropathy,but have some side effects. the investigators believe that offering them Retrobulbar Triamcinolone Acetonide Injection that might halt the progression of the visual acuity and visual field loss if our hypothesis is correct, would greatly improve their chances of avoiding blindness.

Timeline

Start
2015-05
Primary completion
2015-12
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 40 mg Other